Remdesivir expected to be available for COVID-19 patients from next week: top company official

Antiviral drug Remdesivir, approved by the US food and regulatory body for emergency use to treat the COVID-19 patients, is expected to be available by next week, the CEO of the company manufacturing the medicine has said. The announcement was made on Sunday by Dan O’Day, CEO of Gilead Sciences, the pharmaceutical company making the vaccine.

Read the Rest at INDIA TV

Leave a Reply

Your email address will not be published. Required fields are marked *